Brain Tumor and Nanotechnology

Brain Tumors and Nanotechnology explores the complex world of brain tumors and the ground-breaking role that nanotechnology is playing in both detection and treatment. It offers comprehensive and up-to-date strategies in the treatment of brain tumors, with a special emphasis on the revolutionary impact of nanotechnology. It begins with an in-depth analysis of the anatomy of the brain and nervous system, highlighting the constituents of the central nervous system (CNS) such as neurons and glial cells. It also offers a thorough understanding of the intricate structure of the human brain, including the hemispheres, brainstem, diencephalon, and ventricular system. It then reveals the understanding of the complicated nature of brain tumors and the potential for nanotechnology to revolutionize their diagnosis and treatment. Brain Tumors and Nanotechnology will be a longstanding valuable resource for researchers, medical professionals, and students in the field.

Dr. Rishabha Malviya completed his B.Pharm. at Uttar Pradesh Technical University and M.Pharm. (Pharmaceutics) at Gautam Buddha Technical University, Lucknow Uttar Pradesh. His Ph.D. (Pharmacy) work was in the area of novel formulation development techniques. He has 12 years of research experience and has been working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University for the past 8 years. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical excipients. He has authored more than 200 research/review papers for national/international journals of repute with total of 191 cumulative impact factor. He has 58 patents (19 grants, 38 published, 1 filed). He has authored/edited 46 books (Wiley, CRC Press/Taylor and Francis, Springer, River Publishers, IOP publishing and OMICS Publishing) and authored 31 book chapters. His name was included in the world’s top 2% scientist list for the years 2020 and 2021 by Elsevier BV and Stanford University. He is reviewer/editor/editorial board member of more than 50 national and international journals of repute, and has received an Outstanding Reviewer award from Elsevier. He was invited as author for ＂Atlas of Science＂ and a pharma magazine dealing with industry (B2B) ＂Ingredient South Asia Magazines＂.

Arun Kumar Singh completed his B.Pharm. and M.Pharm. at Galgotias University India. He has authored 1 book with IOP Press and 3 authored books are in print with Scrivener Publishing Wiley, Apple Academic Press and River Publishers. He has authored 3 book chapters and published manuscripts with reputed publishers such as Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal of Controlled Release, Current Cancer Therapy Reviews, Recent Advances in Food, Nutrition & Agriculture, and Recent Patents on Anti-Cancer Drug Discovery and Current Cancer Drug Targets.

Professor Sonali Sundram completed her B.Pharm. and M.Pharm. (Pharmacology) at AKTU, Lucknow. She has worked as research scientist with a project of ICMR in King George’s Medical University, Lucknow and then joined BBDNIIT. Currently she is working at Galgotias University, Greater Noida. Her Ph.D. (Pharmacy) work was in the area of neurodegeneration and nanoformulation. Her areas of interest are in neurodegeneration, clinical research, and artificial intelligence. She has authored/edited more than 15 books (Wiley, CRC Press/Taylor and Francis, IOP Publishing, Apple Academic Press/Taylor and Francis, Springer Nature and River Publishers). She has attended as well as organized more than 15 national and international seminars/conferences/workshops. She has more than 8 patents, national and international, to her credit. She has published 6 SCI indexed manuscripts with reputed international publishers. She has delivered oral presentations at international conferences organized in different European countries.